Suchergebnisse - "Canale, Vittorio"

PubPharm (20)

1

Neuropathic pain-alleviating activity of novel 5-HT6 receptor inverse agonists derived from 2-aryl-1H-pyrrole-3-carboxamide

enthalten in: Bioorganic chemistry | 2021

von Drop, M. | Jacquot, F. | Canale, V. | +20

2

Design, Sustainable Synthesis and Biological Evaluation of a Novel Dual α2A/5-HT7 Receptor Antagonist with Antidepressant-Like Properties

enthalten in: Molecules (Basel, Switzerland) | 2021

von Canale, V. | Kotańska, M. | Dziubina, A. | +12

3

2-Phenyl-1H-pyrrole-3-carboxamide as a New Scaffold for Developing 5-HT6 Receptor Inverse Agonists with Cognition-Enhancing Activity

enthalten in: ACS chemical neuroscience | 2021

von Drop, M. | Canale, V. | Chaumont-Dubel, S. | +19

4

Imidazopyridine-Based 5-HT6 Receptor Neutral Antagonists : Impact of N1-Benzyl and N1-Phenylsulfonyl Fragments on Different Receptor Conformational States

enthalten in: Journal of medicinal chemistry | 2021

von Vanda, D. | Canale, V. | Chaumont-Dubel, S. | +12

5

A dual-acting 5-HT6 receptor inverse agonist/MAO-B inhibitor displays glioprotective and pro-cognitive properties

enthalten in: European journal of medicinal chemistry | 2020

von Canale, V. | Grychowska, K. | Kurczab, R. | +17

6

mTOR activation by constitutively active serotonin6 receptors as new paradigm in neuropathic pain and its treatment

enthalten in: Progress in neurobiology | 2020

von Martin, P. | Doly, S. | Hamieh, A. | +11

7

Sustainable Synthesis of a Potent and Selective 5-HT7 Receptor Antagonist Using a Mechanochemical Approach

enthalten in: The Journal of organic chemistry | 2020

von Canale, V. | Frisi, V. | Bantreil, X. | +2

8

Novel antagonists of 5-HT6 and/or 5-HT7 receptors affect the brain monoamines metabolism and enhance the anti-immobility activity of different antidepressants in rats

enthalten in: Behavioural brain research | 2019

von Partyka, A. | Jastrzębska-Więsek, M. | Antkiewicz-Michaluk, L. | +6

9

Amino Acid Hot Spots of Halogen Bonding : A Combined Theoretical and Experimental Case Study of the 5-HT7 Receptor

enthalten in: Journal of medicinal chemistry | 2018

von Kurczab, R. | Canale, V. | Satała, G. | +2

10

Biotransformation of 4-fluoro-N-(1-{2-[(propan-2-yl)phenoxy]ethyl}-8-azabicyclo[3.2.1]octan-3-yl)-benzenesulfonamide, a novel potent 5-HT7 receptor antagonist with antidepressant-like and anxiolytic properties : In vitro and in silico approach

enthalten in: Journal of biochemical and molecular toxicology | 2018

von Słoczyńska, K. | Wójcik-Pszczoła, K. | Canale, V. | +3